Vincerx /
Oqory
Vincerx Pharma and Oqory Amend Business Combination Terms




What happened
Vincerx Pharma, Inc. and Oqory, Inc. amended their binding term sheet effective Jan. 31, 2025. The amendment raised the minimum value for Vincerx stockholders in the combined company from $13.66 million to $14.16 million and waived the remaining $500,000 of interim financing.
The source
Everything on this page comes from the source below.
Vincerx Pharma and Oqory Amend Business Combination Terms
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly